Keros Therapeutics, Inc. (KROS)

15.71 -0.49 (-3.02%) USD  |  NASDAQ  |  Feb 23, 16:00
15.81 +0.10 (+0.64%) Pre-Market: 09:17
More

Keros Therapeutics Operating Income (TTM)

Operating Income (TTM) Chart

View Operating Income (TTM) for KROS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (TTM) Range, Past 5 Years

View Operating Income (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (TTM) Benchmarks

View Operating Income (TTM) Benchmarks
Start Trial
Amicus Therapeutics, Inc. Upgrade
MannKind Corp. Upgrade
Sarepta Therapeutics, Inc. Upgrade
Insmed, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade